A strain-guided trial of cardioprotection in early-stage breast cancer patients on anti-HER2 therapy (PROTECT HER2)
Authors
- Vibhav Rangarajan
- Vera H. Rigolin (ORCID: https://orcid.org/0000-0001-6872-7861)
- Inga Vaitenas
- Haydee Ramirez
- Eli Grunblatt (ORCID: https://orcid.org/0000-0002-3337-7416)
- Abigail S. Baldridge (ORCID: https://orcid.org/0000-0002-1573-0554)
- Adin-Christian Andrei
- Gillian Murtagh (ORCID: https://orcid.org/0000-0001-5963-5244)
- Woo Bin Voss
- Kimberly Chow (ORCID: https://orcid.org/0000-0002-8055-7444)
- Kameswari Maganti (ORCID: https://orcid.org/0000-0002-0449-1754)
- Lua Jafari
- Milica Marion
- Nausheen Akhter (ORCID: https://orcid.org/0000-0001-9423-8578)
- Nikita P. Patel (ORCID: https://orcid.org/0000-0003-4572-702X)
- Fei Gong
- Sasan R. Raissi
- Manyun Zhao
Institutions
- Northwestern University (US)
- Abbott Fund (US)
Publication Details
- Journal
- Cardio-Oncology
- Published
- 2024-11-27
- DOI
- https://doi.org/10.1186/s40959-024-00291-5
- Primary Topic
- Chemotherapy-induced cardiotoxicity and mitigation
- Type
- article
- Field-Weighted Citation Impact
- 0.00